Cargando…
P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430981/ http://dx.doi.org/10.1097/01.HS9.0000971744.43694.69 |
| _version_ | 1785091090000379904 |
|---|---|
| author | Oh, Danielle H. MA, Xiao He, Jackson Kearney, Conor Hogg, Simon J. Newbold, Andrea Fraser, Peter Jennings, Ian G. Brasacchio, Daniella Susanto, Olivia Yew Fong, Chun Dawson, Mark A. Gruber, Emily Kats, Lev Johnstone, Ricky W. Thompson, Philip E. Shortt, Jake |
| author_facet | Oh, Danielle H. MA, Xiao He, Jackson Kearney, Conor Hogg, Simon J. Newbold, Andrea Fraser, Peter Jennings, Ian G. Brasacchio, Daniella Susanto, Olivia Yew Fong, Chun Dawson, Mark A. Gruber, Emily Kats, Lev Johnstone, Ricky W. Thompson, Philip E. Shortt, Jake |
| author_sort | Oh, Danielle H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430981 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309812023-08-17 P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA Oh, Danielle H. MA, Xiao He, Jackson Kearney, Conor Hogg, Simon J. Newbold, Andrea Fraser, Peter Jennings, Ian G. Brasacchio, Daniella Susanto, Olivia Yew Fong, Chun Dawson, Mark A. Gruber, Emily Kats, Lev Johnstone, Ricky W. Thompson, Philip E. Shortt, Jake Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430981/ http://dx.doi.org/10.1097/01.HS9.0000971744.43694.69 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Oh, Danielle H. MA, Xiao He, Jackson Kearney, Conor Hogg, Simon J. Newbold, Andrea Fraser, Peter Jennings, Ian G. Brasacchio, Daniella Susanto, Olivia Yew Fong, Chun Dawson, Mark A. Gruber, Emily Kats, Lev Johnstone, Ricky W. Thompson, Philip E. Shortt, Jake P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title | P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title_full | P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title_fullStr | P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title_full_unstemmed | P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title_short | P1212: RATIONALLY DESIGNED CHIMERIC PI3K-BET BROMODOMAIN INHIBITORS ELICIT CURATIVE RESPONSES IN MYC-DRIVEN LYMPHOMA |
| title_sort | p1212: rationally designed chimeric pi3k-bet bromodomain inhibitors elicit curative responses in myc-driven lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430981/ http://dx.doi.org/10.1097/01.HS9.0000971744.43694.69 |
| work_keys_str_mv | AT ohdanielleh p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT maxiao p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT hejackson p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT kearneyconor p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT hoggsimonj p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT newboldandrea p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT fraserpeter p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT jenningsiang p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT brasacchiodaniella p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT susantoolivia p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT yewfongchun p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT dawsonmarka p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT gruberemily p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT katslev p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT johnstonerickyw p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT thompsonphilipe p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma AT shorttjake p1212rationallydesignedchimericpi3kbetbromodomaininhibitorselicitcurativeresponsesinmycdrivenlymphoma |